Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults

NCT01033877 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

802

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: TdaP vaccine SSI
BIOLOGICAL: Td vaccine SSI

Sponsor

Statens Serum Institut